EVFM

Evofem Biosciences, Inc. Common Stock

Delisted

EVFM was delisted on the 10th of August, 2022.

17 hedge funds and large institutions have $561K invested in Evofem Biosciences, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

Holders
17
Holders Change
+3
Holders Change %
+21.43%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
3
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$168K 104,827 +32,130 +44%
UBS AM
2
UBS AM
Illinois
$145K 90,587 -3,577 -4%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$58K 36,386 +264 +0.7%
FPF
4
FNY Partners Fund
New York
$37K 23,420 +23,420 New
Goldman Sachs
5
Goldman Sachs
New York
$36K 22,326 +6,077 +37%
Citadel Advisors
6
Citadel Advisors
Florida
$23K 14,090 +14,090 New
Millennium Management
7
Millennium Management
New York
$18K 11,173 +11,173 New
Northern Trust
8
Northern Trust
Illinois
$17K 10,345 +10,345 New
Renaissance Technologies
9
Renaissance Technologies
New York
$17K 10,700 +10,700 New
BlackRock
10
BlackRock
New York
$15K 9,146 +9,146 New
Deutsche Bank
11
Deutsche Bank
Germany
$10K 6,839 +6,839 New
Morgan Stanley
12
Morgan Stanley
New York
$8K 5,200 -1,000 -16%
WAS
13
WESPAC Advisors SoCal
California
$4.8K 3,000
UBS Group
14
UBS Group
Switzerland
$3K 2,000
LTFS
15
Ladenburg Thalmann Financial Services
Florida
$1K 500
ARTA
16
A.R.T. Advisors
New York
-18,300 Closed
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$0 42 -457 -92%
Parallax Volatility Advisers
18
Parallax Volatility Advisers
California
$0 151